TRNDi007-B

Cell Line

Provider

External Databases

General Information

• Corbett JL et al. iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery. Frontiers in medicine. 2019;6:265.
• Cheng YS et al. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene. Stem cell research. 2019 May;37:101435.
• Chulpanova Daria S. et al. iPSCs for modeling lysosomal storage diseases. Recent Advances in iPSC Disease Modeling, Volume 1. 2020-00-00.
• Cheng YS et al. Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells. Cells. 2020 Dec 22;10(1).
• Escribá R et al. Inborn errors of metabolism: Lessons from iPSC models. Reviews in endocrine & metabolic disorders. 2021 Dec;22(4):1189-1200.
• Zhang H et al. Case Report: Identification of Compound Heterozygous Mutations in a Patient With Late-Onset Glycogen Storage Disease Type II (Pompe Disease). Frontiers in neurology. 2022;13:839263.
• Aguilar-González A et al. Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies. International journal of molecular sciences. 2022 Jun 4;23(11).
• Christensen C et al. Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene. Stem cell research. 2023 Jun;69:103117.
• Cheng Yu‐Shan et al. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction. Current Protocols. 2023-08-00.
• Martinez‐Montoya Valentina et al. Mutational spectrum and genotype–phenotype correlation in Mexican patients with infantile‐onset and late‐onset Pompe disease. Molecular Genetics & Genomic Medicine. 2024-07-00.

General